Enhancer of anticancer activity in viral therapy and method...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 35/76 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2563103

A medicine capable of effectively and safely enhancing the anticancer activity, especially antitumor immune of viral therapy; and a method of cancer prevention or treatment utilizing the medicine. There is provided an anticancer activity enhancer containing interleukin as an active ingredient, characterized in that it is administered together with a recombinant herpes simplex virus capable of selective replication of cancerous cells.

La présente invention a trait à un médicament capable d'amplifier de façon efficace et sûre l'activité anticancéreuse, en particulier immunitaire anti-tumorale d'une thérapie virale; et à un procédé de prévention ou de traitement d'un cancer utilisant le médicament. L'invention a trait à un amplificateur d'activité anticancéreuse contenant de l'interleukine comme ingrédient actif, caractérisé en ce qu'il est administré conjointement avec un virus de l'herpès simplex recombinant capable d'une réplication sélective de cellules cancéreuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Enhancer of anticancer activity in viral therapy and method... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhancer of anticancer activity in viral therapy and method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancer of anticancer activity in viral therapy and method... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2073463

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.